Erratum: Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus (FEBS Letters (2005) 579 (3421-3426) DOI: 10.1016/j.febslet.2005.05.017);Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus

FEBS Letters

Volumn 579, Issue 16, 2005, Pages 3421-3426

  Samuelsen, Ørjan ^a,b   Haukland, Hanne H ^a,b   Jenssen, Håvard ^a   Krämer, Manuela ^a   Sandvik, Kjersti ^a   Ulvatne, Hilde ^a   Vorland, Lars H ^a,b,c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORTHERN NORWAY REGIONAL HEALTH AUTHORITY   (Norway)

Author keywords

Antimicrobial peptide; Lactoferricin; Resistance; Staphylococcus aureus

Indexed keywords

BACITRACIN; BACITRACIN ZINC; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHLORAMPHENICOL; CLINDAMYCIN; DICLOXACILLIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; INDOLICIDIN; LACTOFERRICIN B; MAGAININ DERIVATIVE; PENICILLIN G; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CROSS RESISTANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 20444369884     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.09.001     Document Type: Erratum

References (40)

1. R.E. Hancock Cationic peptides: effectors in innate immunity and novel antimicrobials Lancet Infect. Dis. 1 2001 156 164
2. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395
3. D. Yang, O. Chertov, and J.J. Oppenheim The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity Cell Mol. Life Sci. 58 2001 978 989
4. M.G. Scott, and R.E. Hancock Cationic antimicrobial peptides and their multifunctional role in the immune system Crit. Rev. Immunol. 20 2000 407 431
5. M.R. Yeaman, and N.Y. Yount Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55 2003 27 55
6. M. Cudic, and L. Otvos Jr Intracellular targets of antibacterial peptides Curr. Drug Targets 3 2002 101 106
7. Y. Shai Mode of action of membrane active antimicrobial peptides Biopolymers 66 2002 236 248
8. H. Ulvatne Antimicrobial peptides: potential use in skin infections Am. J. Clin. Dermatol. 4 2003 591 595
9. A.R. Koczulla, and R. Bals Antimicrobial peptides: current status and therapeutic potential Drugs 63 2003 389 406
10. L.H. Vorland, H. Ulvatne, O. Rekdal, and J.S. Svendsen Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli Scand. J. Infect Dis. 31 1999 467 473
11. A. Peschel, M. Otto, R.W. Jack, H. Kalbacher, G. Jung, and F. Gotz Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides J. Biol. Chem. 274 1999 8405 8410
12. A.S. Bayer, R. Prasad, J. Chandra, A. Koul, M. Smriti, A. Varma, R.A. Skurray, N. Firth, M.H. Brown, S.P. Koo, and M.R. Yeaman In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity Infect. Immun. 68 2000 3548 3553
13. A. Peschel, R.W. Jack, M. Otto, L.V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher, W.F. Nieuwenhuizen, G. Jung, A. Tarkowski, K.P. van Kessel, and J.A. van Strijp Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine J. Exp. Med. 193 2001 1067 1076
14. H. Ulvatne, H.H. Haukland, O. Samuelsen, M. Kramer, and L.H. Vorland Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B J. Antimicrob. Chemother. 50 2002 461 467
15. T. Jin, M. Bokarewa, T. Foster, J. Mitchell, J. Higgins, and A. Tarkowski Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism J. Immunol. 172 2004 1169 1176
16. Haukland, H.H. (2003) Interactions between lactoferricin B and bacteria. Ph.D Thesis, University of Tromsø.
17. S.P. Koo, A.S. Bayer, H.G. Sahl, R.A. Proctor, and M.R. Yeaman Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential Infect. Immun. 64 1996 1070 1074
18. B. Sadowska, A. Bonar, C. von Eiff, R.A. Proctor, M. Chmiela, W. Rudnicka, and B. Rozalska Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants FEMS Immunol. Med. Microbiol. 32 2002 191 197
19. S. Katzif, D. Danavall, S. Bowers, J.T. Balthazar, and W.M. Shafer The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin G Infect. Immun. 71 2003 4304 4312
20. G. Bell, and P.H. Gouyon Arming the enemy: the evolution of resistance to self-proteins Microbiology 149 2003 1367 1375
21. D.A. Steinberg, M.A. Hurst, C.A. Fujii, A.H. Kung, J.F. Ho, F.C. Cheng, D.J. Loury, and J.C. Fiddes Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity Antimicrob. Agents Chemother. 41 1997 1738 1742
22. D.A. Mosca, M.A. Hurst, W. So, B.S. Viajar, C.A. Fujii, and T.J. Falla IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis Antimicrob. Agents Chemother. 44 2000 1803 1808
23. M. Tomita, W. Bellamy, M. Takase, K. Yamauchi, H. Wakabayashi, and K. Kawase Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin J. Dairy Sci. 74 1991 4137 4142
24. J.H. Andersen, S.A. Osbakk, L.H. Vorland, T. Traavik, and T.J. Gutteberg Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts Antiviral Res. 51 2001 141 149
25. J.H. Andersen, H. Jenssen, and T.J. Gutteberg Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir Antiviral Res. 58 2003 209 215
26. J.M. Turchany, S.B. Aley, and F.D. Gillin Giardicidal activity of lactoferrin and N-terminal peptides Infect. Immun. 63 1995 4550 4552
27. T. Isamida, T. Tanaka, Y. Omata, K. Yamauchi, K. Shimazaki, and A. Saito Protective effect of lactoferricin against Toxoplasma gondii infection in mice J. Vet. Med. Sci. 60 1998 241 244
28. W. Bellamy, H. Wakabayashi, M. Takase, K. Kawase, S. Shimamura, and M. Tomita Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin Med. Microbiol. Immunol. (Berl) 182 1993 97 105
29. M.B. Strom, B.E. Haug, O. Rekdal, M.L. Skar, W. Stensen, and J.S. Svendsen Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity Biochem. Cell Biol. 80 2002 65 74
30. H. Jenssen, J.H. Andersen, L. Uhlin-Hansen, T.J. Gutteberg, and O. Rekdal Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate Antiviral Res. 61 2004 101 109
31. B. Fournier, and D.C. Hooper A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus J. Bacteriol. 182 2000 3955 3964
32. I.M. Jonsson, C. von Eiff, R.A. Proctor, G. Peters, C. Ryden, and A. Tarkowski Virulence of a hemB mutant displaying the phenotype of a Staphylococcus aureus small colony variant in a murine model of septic arthritis Microb. Pathog. 34 2003 73 79
33. H.H. Haukland, H. Ulvatne, K. Sandvik, and L.H. Vorland The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm FEBS Lett. 508 2001 389 393
34. H. Ulvatne, and L.H. Vorland Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli Scand. J. Infect. Dis. 33 2001 507 511
35. H. Ulvatne, H.H. Haukland, O. Olsvik, and L.H. Vorland Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes FEBS Lett. 492 2001 62 65
36. H. Ulvatne, O. Samuelsen, H.H. Haukland, M. Kramer, and L.H. Vorland Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis FEMS Microbiol. Lett. 237 2004 377 384
37. J. Takahashi, H. Komatsuzawa, S. Yamada, T. Nishida, H. Labischinski, T. Fujiwara, M. Ohara, J. Yamagishi, and M. Sugai Molecular characterization of an atl null mutant of Staphylococcus aureus Microbiol. Immunol. 46 2002 601 612
38. M.W. Qoronfleh, J.E. Gustafson, and B.J. Wilkinson Conditions that induce Staphylococcus aureus heat shock proteins also inhibit autolysis FEMS Microbiol. Lett. 166 1998 103 107
39. Diarra, M.S., Cloutier A, Perree, M., Petitclerc, D. and Lacasse, P. (2000) Bovine lactoferrin affects growth, morphology and beta-lactamase activity of Staphylococcus aureus isolated from bovine mammary gland. In: Proceedings of the 39th Annual Meeting National Mastitis Council, pp. 188-190.
40. C. Subbalakshmi, and N. Sitaram Mechanism of antimicrobial action of indolicidin FEMS Microbiol. Lett. 160 1998 91 96